• Occult Blood, Fecal
  • Bruton Tyrosine Kinase (BTK) Gene Mutation Analysis
  • Miller-Dieker Syndrome
  • Transferrin and Transferrin Saturation
  • Inherited Insulin Resistance Syndromes (INSR) Genetic Testing
  • Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • The Enhanced Liver Fibrosis (ELF)
  • Sickle Cell Anemia Genetic Analysis
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • T Cell Lymphoma, FISH, Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
Medical Test

Specimen Collection
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.